Drug · DIN 02456370
EPCLUSA
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since August 2, 2016; first marketed August 2, 2016.
- Drug Identification Number (DIN)
- 02456370
- Company (DIN owner)
- Gilead Sciences Canada IncMississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Sofosbuvir and velpatasvir J05AP55
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| SOFOSBUVIR | 400 MG | |
| VELPATASVIR | 100 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 11, 2016: NOC 18265New Drug Submission (NDS)